Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by DryBoneson Nov 21, 2019 1:44pm
95 Views
Post# 30379190

getting ready for the final flush?

getting ready for the final flush?This turd will soon be heading to the east river.  Most Canadian pharma whose management thinks that the NAZ will rescue their failing company will find the stock price settle at 1/10th of its Naz listing price.  Sub $1.00 will be my entry point but it depends on whether the management has succeeded at meeting the quality control points.  If it can do that then this company might finaly succeed at being a supplier of product to the pharma industry.  It will never be a drug company.
<< Previous
Bullboard Posts
Next >>